Catabasis Pharma (CATB) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts CATB Hot Sheet
Join SI Premium – FREE
Catabasis Pharma (NASDAQ: CATB) reported Q1 EPS of ($0.61), $0.03 better than the analyst estimate of ($0.64).
For earnings history and earnings-related data on Catabasis Pharma (CATB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
- Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
